Literature DB >> 17926013

[Practical consequences after MRSA identification in chronic wounds].

J Dissemond1.   

Abstract

In the last years increasing of numbers dermatologic patients with chronic wounds and problem bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) have been reported. Even though it is still unclear if bacterial contamination with MRSA independently interferes with wound healing, both the logistic and therapeutic consequences of identifying MRSA are considerable for the patient and the treatment facility. In this review the practical consequences and the therapy options associated with the identification of MRSA in patients with chronic wounds are considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17926013     DOI: 10.1007/s00105-007-1403-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  40 in total

1.  The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds.

Authors:  P M Mertz; M F Oliveira-Gandia; S C Davis
Journal:  Dermatol Surg       Date:  1999-02       Impact factor: 3.398

Review 2.  [Methicillin-resistant Staphylococcus aureus (MRSA) in chronic wounds: therapeutic options and perspectives].

Authors:  Joachim Dissemond; Andreas Körber; Michaela Lehnen; Steohan Grabbe
Journal:  J Dtsch Dermatol Ges       Date:  2005-04       Impact factor: 5.584

3.  Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus.

Authors:  S Harbarth; S Dharan; N Liassine; P Herrault; R Auckenthaler; D Pittet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  Clinical features associated with nasal Staphylococcus aureus colonisation in Chinese children with moderate-to-severe atopic dermatitis.

Authors:  K L E Hon; M C A Lam; T F Leung; W Y C Kam; M C A Li; M Ip; T F Fok
Journal:  Ann Acad Med Singap       Date:  2005-11       Impact factor: 2.473

Review 5.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Authors:  K Hiramatsu
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

6.  Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.

Authors:  John B Robbins; Rachel Schneerson; Gary Horwith; Robert Naso; Ali Fattom
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

7.  [Treatment of methicillin-resistant Staphylococcus aureus (MRSA) as part of biosurgical management of a chronic leg ulcer].

Authors:  J Dissemond; M Koppermann; S Esser; T Schultewolter; M Goos; S N Wagner
Journal:  Hautarzt       Date:  2002-09       Impact factor: 0.751

8.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

9.  In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.

Authors:  Patrick Grohs; Marie-Dominique Kitzis; Laurent Gutmann
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  New antimicrobial peptide active against Gram-positive pathogens.

Authors:  A Jasir; F Kasprzykowski; V Lindström; C Schalén; A Grubb
Journal:  Indian J Med Res       Date:  2004-05       Impact factor: 2.375

View more
  4 in total

1.  [Panton-Valentine leukocidin in patients with chronic wounds. Results from a clinical investigation in 100 patients].

Authors:  C Hammer; P-M Rath; J Steinmann; M Stoffels-Weindorf; J Klode; J Dissemond
Journal:  Hautarzt       Date:  2014-02       Impact factor: 0.751

2.  [Economic aspects of surgical wound therapies].

Authors:  R E Horch; D Nord; M Augustin; G Germann; M Leffler; A Dragu
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

3.  A retrospective study of risk factors for poor outcomes in methicillin-resistant Staphylococcus aureus (MRSA) infection in surgical patients.

Authors:  Kelechi C Eseonu; Scott D Middleton; Chinyere C Eseonu
Journal:  J Orthop Surg Res       Date:  2011-05-23       Impact factor: 2.359

4.  Evidence-based management strategies for treatment of chronic wounds.

Authors:  Frank Werdin; Mayer Tennenhaus; Hans-Eberhardt Schaller; Hans-Oliver Rennekampff
Journal:  Eplasty       Date:  2009-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.